DATABASE
Home
Database
Who We Are
What We Offer
Register
Sign In
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Name
Category
AstraZeneca beats expectations despite patent cliff
News
AstraZeneca bets on nanotech with Bind Therapeutics deal
News
AstraZeneca CEO says exploring biosimilars market
News
AstraZeneca drops Rigel rheumatoid arthritis pill
News
AstraZeneca falls as RA drug underperforms Humira
News
AstraZeneca falls on disappointing drug study
News
AstraZeneca Gives Up On Rigel's Arthritis Pill
News
AstraZeneca Intends To Acquire Omthera Pharmaceuticals
News
AstraZeneca Pharma India Ltd.
Fund
AstraZeneca PLC
Fund
AstraZeneca PLC
Fund
AstraZeneca PLC
Fund
AstraZeneca PLC
Fund
AstraZeneca PLC
Fund
AstraZeneca PLC
Company
Astrazeneca PLC Common Stock
Company
AstraZeneca scraps Rigel arthritis pill in new R&D blow
News
AstraZeneca scraps Rigel arthritis pill in new R&D blow
News
AstraZeneca to Cut 5,050 Jobs by 2016
News
AstraZeneca unit and WuXi in China joint venture
News
AstraZeneca unites with biotech firm to forge new cancer treatment
News
AstraZeneca wins U-turn on diabetes drug Forxiga
News
AstraZeneca Won’t Seek Approval for Rigel Arthritis Drug
News
AstraZeneca Won’t Seek Approval for Rigel Arthritis Drug
News
AstraZeneca Writes Off $140 Million Following Product Trial
News
Page 944 of 1100